Our perspectives

in one place

News

See all
Statement 21 May 2024

Pharmaceutical trade associations welcome latest announcement of largest number of regulatory agencies recognized under the WHO Listed Authorities Framework

On 21 May, pharmaceutical trade associations at international, European and US-level have welcomed the recognition of the European Medicines Regulatory Network (EMRN) and the United States Food and Drug Administration (FDA) as WHO Listed Authorities, as well as the expanded scope of functions of the Health Sciences Authority (HSA) of Singapore.

Read more
Statement 16 May 2024

Statement at UN multistakeholder hearing on antimicrobial resistance

On 15 May 2024, IFPMA delivered a statement at the UN multistakeholder hearing on antimicrobial resistance, held in New York. The hearing represented an opportunity for all stakeholders to contribute to the ongoing preparatory process for the high-level meeting on AMR, held in September 2024.

Read more
Statement 15 May 2024

IFPMA statement on research with vulnerable populations within the scope of the World Medical Association (WMA) Declaration of Helsinki revision

On 14-15 May 2024, IFPMA was represented at a targeted interdisciplinary discussion within the scope of the WMA Declaration of Helsinki revision. The aim of the meeting was to foster discussion with experts on the paragraphs in the Declaration of Helsinki focused on vulnerable people in research, with a view to contribute the findings to...

Read more
Statement 13 May 2024

WIPO Diplomatic Conference on Genetic Resources and Associated Traditional Knowledge

On 13 May 2024, IFPMA delivered a statement at the WIPO Diplomatic Conference on Genetic Resources and Associated Traditional Knowledge in Geneva, Switzerland. IFPMA and our members support predictable access to genetic resources that can be the starting point for biopharmaceutical research and development. We are concerned that the outcome of this Diplomatic Conference could...

Read more
Statement 23 Apr 2024

Fourth meeting of the Intergovernmental Negotiating Committee (INC-4) on plastics pollution

On 23 April 2024, IFPMA submitted a statement to the Fourth Meeting of the Intergovernmental Negotiating Committee (INC-4) on plastics pollution in Ottawa, Canada. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) lends its full support to an ambitious UN Global Plastics “Instrument” that can help create globally harmonized rules on plastic. This is...

Read more
Statement 22 Apr 2024

Eighth Meeting of the Working Group on Amendments to the International Health Regulations (2005)

On 22 April 2024, IFPMA delivered a statement at the Eighth Meeting of the Working Group on Amendments to the International Health Regulations (2005) in Geneva, Switzerland.

Read more

Join our media mailing list

If you're a journalist, please join our mailing list to receive regular press notifications.

    Top